Here, Trevor Marshall, director of global engineering at Zenith Technologies, goes into detail about how integrating and automating cell therapy production with manufacturing execution systems (MES) will help grow the personalised medicine sector and ultimately benefit patients worldwide.
artificial intelligence
The growth in the clinical adoption of advanced cell therapies is one of many indicators showing an increased focus on personalised medicines. As anticipation builds around cell therapy and the promise it holds, more attention is being paid to the manufacturing strategies that will allow it to benefit more patients.